Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy

Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy

Purpose In present, the use of androgen receptor targeting agents (ARTA) is one of the standard treatments for metastatic castration-resistant prostate cancer (mCRPC) without previous chemotherapy. However, some patients may experience early progression despite ARTA use. Therefore, we analyzed predi...

Full description

Bibliographic Details
Main Authors: Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, Doo Yong Chung
Format: Article
Language:English
Published: Korean Urological Oncology Society 2023-11-01
Series:Journal of Urologic Oncology
Subjects:
castration-resistant prostatic neoplasms
abiraterone acetate
enzalutamide
lymphatic metastasis
Online Access:http://www.e-juo.org/upload/pdf/juo-21-3-264.pdf

Internet

http://www.e-juo.org/upload/pdf/juo-21-3-264.pdf

Similar Items